ZA200204189B - Method of treating hair loss using thyromimetic compounds. - Google Patents

Method of treating hair loss using thyromimetic compounds.

Info

Publication number
ZA200204189B
ZA200204189B ZA200204189A ZA200204189A ZA200204189B ZA 200204189 B ZA200204189 B ZA 200204189B ZA 200204189 A ZA200204189 A ZA 200204189A ZA 200204189 A ZA200204189 A ZA 200204189A ZA 200204189 B ZA200204189 B ZA 200204189B
Authority
ZA
South Africa
Prior art keywords
hair loss
treating hair
thyromimetic compounds
compounds
thyromimetic
Prior art date
Application number
ZA200204189A
Other languages
English (en)
Inventor
Chiang Yuan-Ching Phoebe
Peter Cornelius
Doherty Niall Stephen
Dow Robert Lee
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200204189B publication Critical patent/ZA200204189B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966Triazines or their condensed derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200204189A 2001-05-31 2002-05-27 Method of treating hair loss using thyromimetic compounds. ZA200204189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29496201P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
ZA200204189B true ZA200204189B (en) 2003-11-27

Family

ID=23135661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200204189A ZA200204189B (en) 2001-05-31 2002-05-27 Method of treating hair loss using thyromimetic compounds.

Country Status (19)

Country Link
US (2) US20030007941A1 (hu)
EP (1) EP1262177B1 (hu)
JP (1) JP4051230B2 (hu)
KR (1) KR100523503B1 (hu)
CN (1) CN1314393C (hu)
AT (1) ATE337009T1 (hu)
AU (1) AU784806B2 (hu)
CA (1) CA2387198C (hu)
CY (1) CY1105221T1 (hu)
DE (1) DE60214080T2 (hu)
DK (1) DK1262177T3 (hu)
ES (1) ES2267945T3 (hu)
HK (1) HK1049285B (hu)
HU (1) HUP0201834A3 (hu)
IL (2) IL188110A0 (hu)
PL (1) PL354216A1 (hu)
PT (1) PT1262177E (hu)
TW (1) TWI278313B (hu)
ZA (1) ZA200204189B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US7485298B2 (en) 2002-05-23 2009-02-03 Michael Powell Diagnosis and treatment of human dormancy-related sequellae
WO2003099105A2 (en) * 2002-05-23 2003-12-04 Powell Michael J Diagnosis and treatment of human dormancy syndrome
US7622103B1 (en) * 2003-03-27 2009-11-24 Cielo Jill M Hair and scalp toxin remover composition and method of its making
ES2931949T3 (es) 2005-03-29 2023-01-05 Univ Pennsylvania Minoxidilo para generar nuevos folículos pilosos y tratar la calvicie
US8147815B2 (en) 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
CA2758894C (en) 2009-04-20 2013-09-10 Mitsubishi Tanabe Pharma Corporation Novel thyroid hormone .beta. receptor agonist
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
JP6156371B2 (ja) * 2012-06-08 2017-07-05 大正製薬株式会社 発毛組成物
ES2528392T3 (es) 2012-08-06 2015-02-09 Dr. August Wolff Gmbh & Co. Kg Arzneimittel Eprotiroma para su uso en la prevención y/o tratamiento de trastornos capilares y composiciones de la misma
TWI516272B (zh) 2013-06-05 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
CN104306168B (zh) * 2014-10-15 2017-05-24 华东师范大学 氮‑(4‑氯‑2,5‑二甲氧基苯基)‑5‑异丙基‑2‑甲氧基苯磺酰胺在促进毛发生长的应用
EP3484462B1 (en) 2016-07-15 2022-12-14 Institut Pasteur 5-hydroxytryptamine 1b receptor-stimulating agent for skin and/or hair repair
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
CN111094554A (zh) 2017-09-14 2020-05-01 国立研究开发法人理化学研究所 视网膜组织的制备方法
CN108727344A (zh) * 2018-05-14 2018-11-02 嘉兴特科罗生物科技有限公司 一种化合物及其合成方法和应用
US11628132B2 (en) 2018-10-05 2023-04-18 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
US11766392B2 (en) * 2018-10-05 2023-09-26 Jupiter Wellness, Inc. Minoxidil adjuvant therapies
CN113557311A (zh) 2019-03-13 2021-10-26 大日本住友制药株式会社 移植用神经视网膜的品质评价方法及移植用神经视网膜片
JP2022532706A (ja) 2019-05-08 2022-07-19 アリゴス セラピューティクス,インコーポレーテッド THR-βの調節物質およびその使用方法
US11780825B2 (en) 2020-01-13 2023-10-10 Eccogene (Shanghai) Co., Ltd. Thyroid hormone receptor agonists and use thereof
US20230312527A1 (en) * 2020-08-19 2023-10-05 Chengdu Fanxi Biopharma Co., Ltd. Cyanotriazine derivative, preparation method therefor, and application thereof
WO2022054925A1 (ja) 2020-09-11 2022-03-17 国立研究開発法人理化学研究所 神経網膜を含む細胞凝集体とマトリクスとを含む複合体及びその製造方法
CN116194079A (zh) 2020-09-11 2023-05-30 住友制药株式会社 用于移植用组织的介质
CN116327765A (zh) * 2023-03-27 2023-06-27 广州许愿树毛发医学科技有限公司 莲心碱类化合物作为β2-肾上腺素受体阻断剂的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0137234B1 (en) * 1983-08-17 1990-10-10 The Wellcome Foundation Limited Physiologically active compositions
JPS61165311A (ja) * 1985-01-14 1986-07-26 Takeo Kinji 養毛化粧料
US5061798A (en) * 1985-01-18 1991-10-29 Smith Kline & French Laboratories, Ltd. Benzyl pyridyl and pyridazinyl compounds
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
AU6666594A (en) * 1993-04-20 1994-11-08 Procter & Gamble Company, The Methods of using hesperetin for sebum control and treatment of acne
TW382595B (en) * 1993-10-15 2000-02-21 Merck & Co Inc Pharmaceutical composition for use in arresting and reversing androgenic alopecia
US6255313B1 (en) * 1997-01-23 2001-07-03 Taisho Pharmaceutical Co., Ltd. Sustained release hair growth composition
DE60012700T2 (de) * 1999-03-01 2005-07-28 Pfizer Products Inc., Groton Oxamsäure und deren derivate als liganden der thyroid-rezeptoren
CO5160290A1 (es) * 1999-03-29 2002-05-30 Novartis Ag Derivados de acido fenoxifeniloxamico sustituido .
AU3611500A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Sulfur-containing thyroxane derivatives and their use as hair growth promotors
AU3507700A (en) * 1999-06-01 2000-12-18 University Of Texas Southwestern Medical Center, The Method of treating hair loss using diphenylether derivatives
JP2003500483A (ja) * 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター ビアリール化合物
JP2003500430A (ja) * 1999-06-01 2003-01-07 ザ・ユニバーシティ・オブ・テキサス・サウスウエスタン・メディカル・センター スルホニル・タイロミメチック化合物を用いる毛髪の脱毛を治療する方法
CA2375822A1 (en) * 1999-06-01 2000-12-07 The University Of Texas Southwestern Medical Center Substituted biaryl ether compounds
PT1088819E (pt) * 1999-09-30 2005-09-30 Pfizer Prod Inc Derivados de 6-azauracilo como lignados de receptores da tiroide
WO2001070687A1 (de) * 2000-03-23 2001-09-27 Bayer Aktiengesellschaft Indole zur behandlung von krankheiten die mit schilddrüsenhormonen behandeln werden können
WO2002032408A2 (en) * 2000-10-20 2002-04-25 Novartis Ag Combinations of a thyromimetic compound and a statin

Also Published As

Publication number Publication date
US20080125433A1 (en) 2008-05-29
KR20020092247A (ko) 2002-12-11
CN1314393C (zh) 2007-05-09
EP1262177A3 (en) 2003-09-03
HUP0201834A3 (en) 2004-03-29
HUP0201834A2 (hu) 2003-01-28
EP1262177B1 (en) 2006-08-23
ATE337009T1 (de) 2006-09-15
IL149843A (en) 2008-11-26
ES2267945T3 (es) 2007-03-16
KR100523503B1 (ko) 2005-10-26
IL188110A0 (en) 2008-03-20
AU4446202A (en) 2002-12-05
EP1262177A2 (en) 2002-12-04
AU784806B2 (en) 2006-06-29
CA2387198C (en) 2007-02-13
CN1389203A (zh) 2003-01-08
CA2387198A1 (en) 2002-11-30
TWI278313B (en) 2007-04-11
PT1262177E (pt) 2006-12-29
DE60214080D1 (de) 2006-10-05
IL149843A0 (en) 2002-11-10
JP4051230B2 (ja) 2008-02-20
US20030007941A1 (en) 2003-01-09
DK1262177T3 (da) 2006-11-20
HK1049285B (zh) 2007-08-24
CY1105221T1 (el) 2010-03-03
DE60214080T2 (de) 2007-01-04
PL354216A1 (en) 2002-12-02
HK1049285A1 (en) 2003-05-09
JP2002370978A (ja) 2002-12-24
HU0201834D0 (hu) 2002-08-28

Similar Documents

Publication Publication Date Title
HK1049285A1 (en) Method of treating hair loss using thyromimetic compounds
HK1145692A1 (zh) 人血管生成素- 的特異結合劑
EP1545587A4 (en) LACTOFERRIN COMPOSITIONS AND METHODS OF TREATING WOUNDS
BR0211251B1 (pt) composição para o tratamento de cabelo e/ou couro cabeludo.
HK1048831A1 (en) Human ctla-4 antibodies and their uses
BR0003184A (pt) Métodos para tratamento de pigmentação da pele
BR0202519B1 (pt) métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
BR0201862A (pt) Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
BR0111785A (pt) Composições e métodos para tratamento de candidìase
GB9806029D0 (en) 8a-Azalides as veterinary antimicrobial agents
DK1043028T3 (da) Phytase til forebyggelse eller behandling af mastitis
DE60137459D1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
AU2003290970A8 (en) Compositions and method for treating affective, painful or allergic disorders
GB0003234D0 (en) Method of treatment
AU2003249999A8 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours
ATE411739T1 (de) Verfahren und mittel zur behandlung von krebs bei hunden
EP1328662A4 (en) NUCLEIC ACID MOLECULES FROM PERITROPHINE OF FLUIDS, PROTEINS AND ITS APPLICATIONS
RU2001101227A (ru) Антибактериальное средство для лечения кожных заболеваний
UA33231A (uk) Спосіб добору великої рогатої худоби з прогнозованим ефектом селекції по молочності і м'ясності